The diabetic shoes market size is projected to be valued at US$ 8.6 billion in 2023, and is expected to rise to US$ 16.0 billion by 2033. The sales of diabetic shoes are anticipated to capture a significant CAGR of 6.4% during the forecast period.
The growing number of instances and public awareness of this chronic illness are being fueled by shifting market trends, which are anticipated to promote both industry and market growth over the next years.
Most people in the world are affected by Type 1 and Type 2 diabetes. Problems including neuropathy, loss of feeling, and numbness in the foot are brought on by high blood sugar levels. To prevent foot complications in a diabetic condition, proper foot care is crucial. Due to this high occurrence, medical professionals advise patients to wear diabetic shoes. Additionally, online merchants encourage their customers to purchase these shoes over other types of footwear by emphasizing their optimum effectiveness.
Diabetic shoes are a helpful addition to a healthy diet, an active lifestyle, and the right medications for managing diabetes.
The therapeutic shoes’ exceptional comfort, added depth, flexibility, and lightweight qualities, as well as their availability in attractive designs and colors, all contribute to the expansion of the global market for diabetic shoes.
Download a sample to obtain additional highlights and key points on various market segments and their impact in the coming years @
https://www.futuremarketinsights.com/reports/sample/rep-gb-1191
Key Takeaways from the Market Study:
- Based on product type, dress shoe leads the segment with a growth rate of 6.4%. The growing working-class population and the rising demand for trending designs that suit consumer outfits would serve as growth
- Women are more prone to diabetes due to their high SHBG levels. Growing awareness among women to maintain their physique and health would lead them to be the top end-users and lead the segment with a growth rate of 5.8%
- The segment of online retailers is predicted to expand at a phenomenal CAGR of 10.8% throughout the projected period in terms of the sales channel. The segment’s expansion can be attributed to consumers’ increasing preference for online shopping.
- The United States leads the market with a revenue share of US$ 5.7 billion. The population in the United States is more concerned about their health and hygiene, which leads them to spend highly on healthcare solutions.
- China is among the most lucrative countries in the region, contributing a CAGR of 5.8% by 2033. The growing geriatric population is a crucial factor supporting the growth. Investments from various key businesses in the region are likely to serve as a potential opportunity for the market to grow.
Competitive Landscape:
To grow their company internationally and gain a competitive edge in the global diabetic shoes market, top diabetic shoe manufacturers have implemented a variety of organic and inorganic strategies, including new product launches, mergers, partnerships, acquisitions, the strengthening of online sales channels, and the establishment of new manufacturing facilities.
Are you looking for customized information related to the latest trends, drivers, and challenges? Speak to Our Analyst@ https://www.futuremarketinsights.com/ask-question/rep-gb-1191
Latest Developments in the Diabetic Shoes Market:
- The development of smart footwear was revealed by Sensoria Health and Optima Molliter at the International Consumer Electronics Show (CES) in January 2018. Motus Smart footwear was unveiled by Microsoft, Optima Molliter, and Sensoria Health later in October 2019.
- Orpyx SI sensory insoles were introduced in December 2019 by Orpyx Medical Technologies Inc., a leader in digital health therapies. These insoles may inform patients in real-time and enable them to take action against high-pressure foot areas that could cause tissue breakdown.
- New diabetic footwear from Von Wellex, Germany was introduced in 2021, a footwear that can reduce the possibility of foot issues.
| Key Companies Profiled | Asics, Drewshoe, Incorporated, Orthofeet Inc., DARCO International, Inc., Clearwell Mobility Company, Supad, Aetrex Worldwide, Inc., Gravity Defyer Corp., Kinetec Medical Products Ltd, Horng Shin Footwear Co., Watts Footwear, DJO, LLC (Dr. Comfort), Advance Diabetic Solution, Dr. Zen Products, Inc., and Sensoria Health |
Key Segments Covered in the Diabetic Shoes Market Report
By Product Type:
- Dress Shoes
- Running Shoes
- Strolling Shoes
- Others
By Patient Type:
- Outpatient
- Inpatient
By End User:
- Men
- Women
By Width:
- Narrow
- Medium
- Wide
- Others
By Sales Channel:
- Direct Sales
- Footwear Specialty Stores
- Medical & Healthcare Centers
- Online Retailers
- Mono-brand Stores
- Other Sales Channel
About FMI:
Future Market Insights, Inc. (ESOMAR certified, Stevie Award – recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs